Owner Xenon Pharmaceuticals Inc.

Inventors Chafeev, Mikhail; Chowdhury, Sultan; Fraser, Lauren; Fu, Jianmin; Langille, Jonathan; Liu, Shifeng; Sun, Jianyu; Sun, Shaoyi; Sviridov, Serguei; Wood, Mark; Zenova, Alla; Jia, Qi; Cadieux, Jean-Jacques; Gauthier, Simon J.; Douglas, Amy Frances; Hsieh, Tom; Chakka, Nagasree; Cikojevic, Zoran

Agent Davies Collison Cave

Pub. Number AU-A-2009303468

PCT Pub. Number WO2010/045251

Priority 61/106,464 17.10.08 US

Filing date 13 October 2009

Wipo publication date 22 April 2010

C07D 491/20 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or